Patent · US Active

Method and product for treatment and/or prevention of complications of prematurity

US8518877B2 · kind B2 · utility

0Cited by

3References

38Claims

0Family size

Assignee

PREMACURE AB · SE

Inventors

Ann Hellstrom · Hagfors, SE
Chatarina Lofqvist · Mölndal, SE
Lois Smith · Newton, US

Key dates

Filing date	Apr 18, 2008
Grant date	Aug 27, 2013
Priority date	—
Expiry date	Mar 31, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, such combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.